Dr. Mahesha Ranasoma has been appointed as the new Managing Director of Hemas Pharmaceuticals and Hemas Surgicals & Diagnostics, marking a significant milestone in the company’s ongoing journey of excellence in the healthcare sector. With over 25 years of cross-sector leadership experience, Dr. Ranasoma’s appointment is set to drive a new era in healthcare leadership, strengthening Hemas’ position as a trusted partner in delivering high-quality and innovative healthcare solutions to Sri Lankans.
In a strategic move aimed at strengthening its position in Sri Lanka’s healthcare sector, Hemas Pharmaceuticals and Hemas Surgicals & Diagnostics have appointed Dr. Mahesha Ranasoma as their new Managing Director. This leadership change highlights the company’s continued commitment to innovation and excellence in the healthcare industry.
A Strong Legacy in Sri Lanka’s Healthcare Sector
Hemas Pharmaceuticals has been a cornerstone of Sri Lanka’s healthcare industry for over six decades. The company’s long-standing partnerships with global healthcare brands have allowed it to provide high-quality, safe, and effective healthcare solutions. With a focus on maintaining the highest standards of quality, compliance, and ethical practices, Hemas has become a trusted partner to various stakeholders in the healthcare sector.
Dr. Ranasoma’s Expertise in Healthcare Leadership
With over 25 years of cross-sector leadership experience, Dr. Mahesha Ranasoma brings valuable expertise to his new role at Hemas Pharmaceuticals. Before joining Hemas, Dr. Ranasoma served as the CEO of Global Rubber Industries (GRI) and the Managing Director of Dipped Products PLC under the Hayleys Group. He also held regional leadership roles, including Country Chairman of Shell Sri Lanka and General Manager of Shell Vietnam, where he spearheaded initiatives in growth, innovation, and operational excellence.
Hemas Healthcare Chairman, Murtaza Esufally, expressed confidence in Dr. Ranasoma’s leadership abilities, highlighting how his purpose-driven approach aligns with Hemas’ values. “Dr. Ranasoma’s proven ability to lead complex operations will be essential in furthering our mission to strengthen our healthcare partnerships and drive long-term growth in Sri Lanka,” Esufally stated.
A Vision for Strengthening Healthcare Leadership
Dr. Ranasoma shared his enthusiasm about joining Hemas Pharmaceuticals at such a transformative time in the healthcare sector. “I am honored to take on this role at Hemas Pharmaceuticals. Our goal is to enhance the accessibility of quality medicines while continuing to strengthen our market leadership,” said Dr. Ranasoma. “By working closely with our talented team and esteemed partners, we will contribute significantly to the healthcare ecosystem in Sri Lanka.”
Under his leadership, Hemas Pharmaceuticals and Hemas Surgicals & Diagnostics are poised to continue being a reliable partner in delivering innovative and high-quality healthcare solutions across the country.
Tags: #HealthcareLeadership #HemasPharmaceuticals #SriLankaHealthcare